RxDoctor Payments Data

John Siddoway, MD

Otolaryngology · Ogden, UTNPI 1356338388

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations.

$1,679in general payments, 2019–2025

Across 116 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$358
  • Regeneron Healthcare Solutions, Inc.$290
  • Sanofi$235
  • GSK$149
  • Pharming Healthcare, Inc.$143
  • Intersect ENT, Inc.$71
  • plus $434 from 15 others

What the payments were for

  • Food & beverage$1,679100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,679 in reported general payments places this provider in the 60th percentile of 104 otolaryngology providers in Utah.

See all otolaryngology providers in Utah

Medicare billing

Part B allowed, 2024
$20,752
Medicare patients
98
Services billed
375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole41$726
Montelukast Sodium64$490
Famotidine21$443
Albuterol Sulfate HfaAlbuterol Sulfate11$381
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid19$199
Prednisone24$195
Pantoprazole Sodium24$194

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →